Total planned funding: $520,060,914
Clear active filters
Namibia
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Namibia | $520,060,914 |
Organizational Types
NGO | $137,377,939 |
Private Contractor | $111,230,746 |
Own Agency | $71,334,173 |
Host Country Government Agency | $68,169,695 |
University | $55,719,547 |
Unknown | $50,994,791 |
Parastatal | $10,534,579 |
Other USG Agency | $7,473,999 |
Implementing Agency | $3,653,807 |
Multi-lateral Agency | $2,040,000 |
FBO | $1,531,638 |
Program Areas
Treatment | $157,407,924 |
Prevention | $112,104,736 |
Care | $102,410,071 |
Governance and Systems | $72,159,400 |
Management and Operations | $40,229,695 |
Testing | $35,749,088 |
Budget Codes
HTXS: Treatment: Adult Treatment | $135,202,855 |
HKID: Care: Orphans and Vulnerable Children | $45,899,582 |
HVMS: Management and Operations | $40,229,695 |
HVOP: Sexual Prevention: Other Sexual Prevention | $39,635,239 |
HVCT: Testing: HIV Testing and Counseling | $35,749,088 |
HVSI: Strategic Information | $31,536,590 |
OHSS: Health Systems Strengthening | $30,421,749 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $27,192,568 |
HBHC: Care: Adult Care and Support | $26,227,342 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $22,683,033 |
HVTB: Care: TB/HIV | $21,700,634 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $17,330,251 |
PDTX: Treatment: Pediatric Treatment | $12,456,050 |
HLAB: Laboratory Infrastructure | $10,201,061 |
HTXD: Treatment: ARV Drugs | $9,749,019 |
PDCS: Care: Pediatric Care and Support | $8,582,513 |
HMBL: Biomedical Prevention: Blood Safety | $4,260,220 |
HMIN: Biomedical Prevention: Injection Safety | $1,003,425 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $0 |
Top Partner Programs
Potentia Namibia:
$66,021,462
Countries/Regions
University of Washington:
$45,029,142
Countries/Regions
Not Available:
$41,718,003
Countries/Regions